ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.500
0.00 (0.00%)
At close: Feb 24, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 75.12 million as of March 2, 2026. Its market cap has decreased by -49.94% in one year.
Market Cap
75.12M
Enterprise Value
73.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.50
Market Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 75.12M, an increase of 420.57%. That is a compound annual growth rate of 100.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 75.12M | -37.50% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 150.46M |
| Medicenna Therapeutics | 75.08M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 62.62M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |